Starpharma is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications, and aims to create value through the commercialisation of its proprietary products. In striving for this objective, Starpharma acknowledges its role within society and believes its success will deliver long term positive benefits to all stakeholders. Starpharma’s corporate governance principles and code of conduct set the framework for how the company, management and employees are expected to conduct themselves: always ethically and responsibly.
Our People
The employees of Starpharma are critical for achieving business success. To ensure Starpharma remains a safe, healthy, and attractive workplace for our employees, Starpharma has established work place policies and practices. Policies assist to ensure employees have engaging and satisfying roles, receive periodic assessments and feedback on performance, provide ongoing training and career development, and ensure a balanced work and home life. Starpharma’s Code of Conduct reflects the core values of the Company and sets out standards of behaviour in matters including equal employment opportunity and best practice in recruitment.
Employees are rewarded for their performance, dedication, and contribution to the results of Starpharma. Employees are recruited into and retained in positions based on merit. A balance of skills, expertise and opinion, as well as gender and diversity are viewed as important cultural elements within the collegiate team environment. The Board has adopted a Diversity Policy to provide a framework for Starpharma to achieve a number of diversity objectives, with an initial focus on gender.
Employee equity participation schemes are used to allow all staff to share in the business success of the Company and to assist in aligning the objectives of employees with those of shareholders.
Occupational health and safety is considered every employee’s responsibility, with an active committee structure to eliminate, reduce or mitigate risks associated with Starpharma’s activities. Occupational Health & Safety Committee members represent all sections of the workplace including management and employees.
The Community
The very nature of Starpharma products affords the opportunity of changing lives for the better. Through innovative research and development, Starpharma is creating products for needs which are currently unmet, either within the public health, medical, life sciences or other markets.
All of our pharmaceutical products and our clinical research activities comply with strict regulatory and ethical approval processes. These include the FDA in the United States and other regulatory bodies as applicable.
Our Partners
Starpharma has established important business and scientific partnerships with leading global companies, international scientific and medical research organisations and key governmental and non-governmental departments and institutions. These relationships offer critical analysis of research concepts from world experts in their field and provide the pathway for products to enter the market and change daily lives.
The Environment
The broad application of Starpharma’s dendrimer research extends into projects that may assist the environment. Research in the fields of agrochemicals and water may improve existing products and reduce the negative impact of current practices on the environment. More effective chemical formulations for agrochemicals could reduce the frequency of application and potentially improve the environmental profile of such products. Early studies in combining the company’s proprietary dendrimer technology with major agrochemicals indicate that improvements such as enhanced solubility, better adhesion to plants and modification of soil penetration properties are possible.
In conducting its research and operations Starpharma has processes in place to ensure that all wastes products (albeit relatively minor in volume) are disposed of strictly in accordance with relevant environment regulations.
Read the Corporate Governance Statement from the 2011 Annual Report (pdf file, 81kb).
Policy Downloads:
Code of Conduct (pdf file, 31kb)
Diversity Policy (pdf file, 106kb)
Risk Management Policy ( pdf file, 714kb)
Securities Dealing Policy ( pdf file, 53kb)
VivaGel® represents a potential breakthrough in women’s health. VivaGel® is a microbicide in development to prevent the transmission of STIs including HIV and genital herpes worldwide. VivaGel® has application in both the developed and developing countries with the potential to offer a safe, affordable and discreet means for women to protect themselves against important diseases.